rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

CryoPort, Inc.

CYRX · Nasdaq

Health CareLife-science toolsLeading

CYRX stood above a rising 150-day average in 41 of the last 52 weekly readings, including each of the last 26 weeks. It is 19.1% above that average now. Life Science Tools & Research Services: 52% of its 79 stocks in an uptrend (+4 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Leading
Weeks in an uptrend
26 in a row
Industry in uptrend
52% +4 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$9.2M
Officials’ trades on record
20
Institutions holding
174 (+23)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 41 of 52 weeks.

17 Apr – 16 Oct
26%41%57%Apr 26Jun 26Jul 26Sep 26Oct 26

Life-science tools: About half its stocks are in an uptrend and the share has been climbing. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$7.0M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

20 disclosed lines: House 20, Senate 0, executive 0; 4 people.

WhoDidAmountTraded
Josh Gottheimer House: U.S. House ClerkNJ05soldjoint$1k–$15k15 Sep 2023filed 15 Oct 2023
Donald S. Beyer, Jr. House: U.S. House ClerkVA08sold$1k–$15k28 Feb 2022filed 3 Mar 2022
Donald S. Beyer, Jr. House: U.S. House ClerkVA08sold$1k–$15k31 Jan 2022filed 1 Feb 2022
Donald S. Beyer, Jr. House: U.S. House ClerkVA08sold$1k–$15k14 Jan 2022filed 1 Feb 2022
Donald S. Beyer, Jr. House: U.S. House ClerkVA08sold$1k–$15k13 Jan 2022filed 1 Feb 2022
Donald S. Beyer, Jr. House: U.S. House ClerkVA08sold$1k–$15k21 Sep 2021filed 1 Oct 2021
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA39sold$1k–$15k24 Nov 2020filed 15 Dec 2020
Donald S. Beyer, Jr. House: U.S. House ClerkVA08bought$1k–$15k17 Nov 2020filed 1 Dec 2020
Josh Gottheimer House: U.S. House ClerkNJ05sold$1k–$15k13 Nov 2020filed 9 Dec 2020
Donald S. Beyer, Jr. House: U.S. House ClerkVA08bought$1k–$15k2 Nov 2020filed 1 Dec 2020
Donald S. Beyer, Jr. House: U.S. House ClerkVA08sold$1k–$15k14 Jul 2020filed 9 Aug 2020
Donald S. Beyer, Jr. House: U.S. House ClerkVA08sold$1k–$15k7 May 2020filed 31 May 2020

Insiders

Buy orders, 12 months0
Sale orders, 12 months14
Buyers · sellers0 · 5
WhoDidSharesTraded
Jerrell SheltonPresident, CEOsold28,800at $14.9111 Aug 2026filed 11 Aug 2026
Edward J. ZecchiniChief Digital and Tech Officersold33,600at $14.4711 Jun 2026filed 12 Jun 2026
Edward J. ZecchiniChief Digital and Tech Officersold1,400at $15.2310 Jun 2026filed 12 Jun 2026
Ramkumar MandalamDirectorsold23,214at $15.448 Jun 2026filed 8 Jun 2026
Robert StefanovichChief Financial Officersold169,427at $16.274 Jun 2026filed 8 Jun 2026
Mark W. SawickiChief Scientific Officersold1,341at $8.1823 Mar 2026filed 25 Mar 2026
Jerrell SheltonPresident, CEOsold2,894at $8.1823 Mar 2026filed 25 Mar 2026
Robert StefanovichChief Financial Officersold1,094at $8.1823 Mar 2026filed 25 Mar 2026
Robert StefanovichChief Financial Officersold2,743at $8.0016 Mar 2026filed 16 Mar 2026
Mark W. SawickiChief Scientific Officersold3,235at $8.0016 Mar 2026filed 17 Mar 2026
Jerrell SheltonPresident, CEOsold7,918at $8.0016 Mar 2026filed 17 Mar 2026
Edward J. ZecchiniOfficersold2,014at $8.0016 Mar 2026filed 17 Mar 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders174+23 on the quarter
New · exited39 · 15
Reported value$688.4M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
BlackRock, Inc.added · filed 7 Aug 20264,218,434$66.2M+237,536+6.0%
CADIAN CAPITAL MANAGEMENT, LPreduced · filed 14 Aug 20262,920,681$45.9M-1,855,662−38.9%
MORGAN STANLEYreduced · filed 13 Aug 20262,276,741$35.7M-2,299,989−50.3%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 20262,151,943$33.8M+33,087+1.6%
MILLENNIUM MANAGEMENT LLCreduced · filed 14 Aug 20261,724,726$27.1M-1,245,738−41.9%
FRED ALGER MANAGEMENT, LLCreduced · filed 14 Aug 20261,545,293$24.3M-154,086−9.1%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 20261,312,370$20.6M+64,235+5.1%
MAK CAPITAL ONE LLCreduced · filed 14 Aug 20261,277,359$20.1M-145,906−10.3%
First Eagle Investment Management, LLCadded · filed 5 Aug 20261,271,424$20.0M+526,575+70.7%
Assenagon Asset Management S.A.reduced · filed 8 Jul 20261,152,311$18.1M-343,372−23.0%
31 Mar 2023 – 30 Jun 2026
128150172Mar 23Dec 23Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

Jerrell Shelton Company insiderPresident, CEO · last 11 Aug 202617 · 28
Edward J. Zecchini Company insiderChief Digital and Tech Officer · last 11 Jun 20260 · 13
Ramkumar Mandalam Company insiderDirector · last 8 Jun 20260 · 12
Daniel M. Hancock Company insiderDirector · last 5 Jun 20260 · 9
Linda Baddour Company insiderDirector · last 5 Jun 20260 · 0
Robert J. Hariri Company insiderDirector · last 5 Jun 20260 · 11
Robert Stefanovich Company insiderChief Financial Officer · last 4 Jun 20261 · 19
Mark W. Sawicki Company insiderChief Scientific Officer · last 23 Mar 20260 · 13
Richard J. Berman Company insiderDirector · last 17 May 20240 · 17
Josh Gottheimer HouseNJ05 · last 15 Sep 20231 · 2
Donald S. Beyer, Jr. HouseVA08 · last 28 Feb 20227 · 7
Blackstone Group Management L.l.c. Company insider10% owner · last 16 Nov 20210 · 2

Same industry

OABI OmniAbLeading+65%
TXG 10x GenomicsLeading+60%
AVTR AvantorLeading+47%
ILMN IlluminaLeading+44%
RVTY RevvityLeading+37%
MASS 908 DevicesLeading+31%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202547.1%
Operating profit marginFY 2025 · to 31 Dec 2025-20.9%
Free cash flow marginFY 2025 · to 31 Dec 2025-14.2%
Return on capital employedFY 2025 · to 31 Dec 2025-6.7%
Cash conversionFY 2025 · to 31 Dec 2025-11.0%
Research spendFY 2025 · to 31 Dec 20259.7%
Share count trendFY 2025 · to 27 Feb 20260.0%
Cash and equivalentsFY 2025 · to 31 Dec 2025$250.5M
Free cash flowFY 2025 · to 31 Dec 2025−$25.0M

Analyst forecasts

No analyst forecasts yet.